Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Endo, F

Class:IdPerson:2285542
_displayNameEndo, F
_timestamp2012-05-28 12:16:21
created[InstanceEdit:2285516] Jassal, B, 2012-05-28
firstnameF
initialF
surnameEndo
(author)[LiteratureReference:2285513] Clinical and molecular analysis of a Japanese boy with Morquio B disease
[LiteratureReference:5660887] Structure of the SLC7A7 gene and mutational analysis of patients affected by lysinuric protein intolerance
[LiteratureReference:9864942] Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease
[LiteratureReference:9864963] Maple syrup urine disease caused by a partial deletion in the inner E2 core domain of the branched chain alpha-keto acid dehydrogenase complex due to aberrant splicing. A single base deletion at a 5'-splice donor site of an intron of the E2 gene disrupts the consensus sequence in this region
[LiteratureReference:9864967] Maple syrup urine disease: a possible biochemical basis for the clinical heterogeneity
[LiteratureReference:9956151] Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency
[LiteratureReference:9956158] Expression of four mutant human ornithine transcarbamylase genes in cultured Cos 1 cells relates to clinical phenotypes
[LiteratureReference:9956178] Phenotypic variability in male patients carrying the mutant ornithine transcarbamylase (OTC) allele, Arg40His, ranging from a child with an unfavourable prognosis to an asymptomatic older adult
[LiteratureReference:9957635] Ten novel mutations of the ornithine transcarbamylase (OTC) gene in OTC deficiency
[Change default viewing format]
No pathways have been reviewed or authored by Endo, F (2285542)